AgingResearch.News
Aging clocksHumansPeer-reviewed

Accelerated biological aging links to higher gout risk and increased mortality

Data from NHANES and the UK Biobank show phenotypic and biological age measures track with gout incidence and subsequent survival.

Maturitas · Zhao H et al. · Paper published 25 Sep 2026

Paper

In human participants from the National Health and Nutrition Examination Survey (NHANES) and the UK Biobank, researchers examined whether biological age tracks with gout and mortality. The investigators quantified biological aging using the Klemera-Doubal method (KDMAge) and phenotypic age (PhenoAge). In the cross-sectional NHANES cohort, each one-year advance in KDMAge or PhenoAge was associated with a 4% higher risk of gout. In the prospective UK Biobank cohort, accelerated biological aging predicted incident gout, with hazard ratios of 1.80 for KDMAge advance and 1.69 for PhenoAge advance. Among individuals diagnosed with gout, accelerated biological aging was linked to a 21% to 134% increase in the risk of all-cause mortality.

Why it matters

The findings show that composite biological aging markers associate with metabolic and inflammatory joint disease. They indicate that multi-system aging measures capture variations in gout vulnerability and long-term survival beyond chronological age alone.

Caveats

The findings derive from observational cohorts and cannot establish causality. Gout identification methods also varied, relying on self-reported physician diagnoses in NHANES and inpatient hospital records in the UK Biobank.

Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.

The paper

Association of biological aging with gout risk and all-cause mortality: Evidence from NHANES and UK Biobank

Zhao H, Xu Y, Gao Y et al.

Maturitas · 25 Sep 2026 · Peer-reviewed

Relevance
Relevant
News value
Notable
Evidence
Humans
Status
Peer-reviewed
See all